ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Denali Therapeutics Inc

Denali Therapeutics Inc (DNLI)

15.56
-0.55
(-3.41%)
Closed April 24 4:00PM
15.56
0.00
( 0.00% )
Pre Market: 7:00AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
15.56
Bid
15.70
Ask
16.86
Volume
-
0.00 Day's Range 0.00
15.45 52 Week Range 33.31
Market Cap
Previous Close
15.56
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,257,201
Shares Outstanding
139,160,239
Dividend Yield
-
PE Ratio
-14.91
Earnings Per Share (EPS)
-1.04
Revenue
330.53M
Net Profit
-145.22M

About Denali Therapeutics Inc

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
1970
Denali Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker DNLI. The last closing price for Denali Therapeutics was $15.56. Over the last year, Denali Therapeutics shares have traded in a share price range of $ 15.45 to $ 33.31.

Denali Therapeutics currently has 139,160,239 shares outstanding. The market capitalization of Denali Therapeutics is $2.17 billion. Denali Therapeutics has a price to earnings ratio (PE ratio) of -14.91.

Denali Therapeutics (DNLI) Options Flow Summary

Overall Flow

Bearish

Net Premium

-26k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

DNLI Latest News

Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered...

Denali Therapeutics Announces $500 million Private Placement Equity Financing

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.16-6.9377990430616.7216.9515.47155024516.04986747CS
4-5.3-25.407478427620.8621.0415.47112341317.78022293CS
12-0.6-3.7128712871316.1623.5215.47125720118.90681002CS
26-3.9-20.041109969219.4623.8115.45114058619.09959797CS
52-9.22-37.20742534324.7833.3115.4592549321.77100343CS
156-42.03-72.981420385557.5979.715.4572602631.02872724CS
260-8.58-35.542667771324.1493.9412.3964383632.97313504CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ILAGIntelligent Living Application Group Inc
$ 0.89
(64.81%)
5.66M
AIREreAlpha Tech Corporation
$ 1.63
(40.52%)
3.53M
MRINMarin Software Incorporated
$ 2.95
(25.00%)
30
CDTXCidara Therapeutics Inc
$ 15.30
(24.49%)
63.57k
VCNXVaccinex Inc
$ 6.20
(23.88%)
380
HUBCWHub Cyber Security Ltd
$ 0.0164
(-31.35%)
3
FBLGraniteShares ETF Trust GraniteShares
$ 19.05
(-28.84%)
122.51k
BPTSBiophytis SA
$ 7.30
(-24.77%)
2.93k
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.3397
(-20.13%)
1.22M
ADTXAditxt Inc
$ 2.02
(-14.77%)
2
ILAGIntelligent Living Application Group Inc
$ 0.89
(64.81%)
5.66M
SBFMSunshine Biopharma Inc
$ 0.9976
(7.27%)
4.15M
AIREreAlpha Tech Corporation
$ 1.63
(40.52%)
3.53M
NUWENewellis Inc
$ 0.2899
(14.99%)
1.97M
CYNCYNGN Inc
$ 0.102
(-4.32%)
1.94M

DNLI Discussion

View Posts
conix conix 1 year ago
DNLI on Seeking Alpha

https://seekingalpha.com/article/4570210-denali-need-patient-data-to-justify-that-high-valuation
πŸ‘οΈ0
seward seward 2 years ago
Up big, why?
πŸ‘οΈ0
seward seward 3 years ago
Up 5 pts AH news or random bid ?
πŸ‘οΈ0
seward seward 3 years ago
Add 55.55

Been holding for 100+, flipping small shares
πŸ‘οΈ0
seward seward 3 years ago
More flipping.

Filled for one share at 57 this morning. If it hits 62 I can buy coffee.

hans
πŸ‘οΈ0
seward seward 3 years ago
Good earnings, flipped some in low 60s
πŸ‘οΈ0
seward seward 3 years ago
Adding a little on pullbacks, still looking to hold till it breaks 100 and then sone.
πŸ‘οΈ0
seward seward 3 years ago
Best stock I’ve ever seen. Next stop 100 ?
πŸ‘οΈ0
seward seward 3 years ago
Up up up. I suppose I should sell it some day. Maybe over 100 ?
πŸ‘οΈ0
seward seward 4 years ago
14 may not be in the cards. I may wait for 100.

hans
πŸ‘οΈ0
seward seward 5 years ago
Up nice today for no apparent reason.

hans
πŸ‘οΈ0
Glider549 Glider549 5 years ago
Interesting .
Stockconsultant daut kom sent me here.
Any debt? Toxic debt?
πŸ‘οΈ0
Golden Cross Golden Cross 5 years ago
Back to $14 then do it again!
πŸ‘οΈ0
Golden Cross Golden Cross 5 years ago
Looking into if they have a stake in private company Blaze Bioscience and their scorpion venom..GLTA
πŸ‘οΈ0
seward seward 5 years ago
In at 14.30, already near 17. Lucky.
πŸ‘οΈ0
seward seward 5 years ago
"Announces Advancement and Expansion of Its LRRK2 Inhibitor Clinical Program for Parkinson’s Disease"

I bought some today

hans
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock